A detailed history of Apollo Management Holdings, L.P. transactions in Mannkind Corp stock. As of the latest transaction made, Apollo Management Holdings, L.P. holds 664,113 shares of MNKD stock, worth $3.79 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
664,113
Previous 964,113 31.12%
Holding current value
$3.79 Million
Previous $6.05 Million 29.47%
% of portfolio
0.06%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$5.93 - $7.44 $1.78 Million - $2.23 Million
-300,000 Reduced 31.12%
664,113 $4.27 Million
Q1 2023

May 15, 2023

BUY
$3.95 - $5.63 $3.81 Million - $5.43 Million
964,113 New
964,113 $3.95 Million
Q4 2021

Feb 14, 2022

BUY
$4.05 - $5.37 $1.35 Million - $1.79 Million
334,226 New
334,226 $1.46 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.47B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Apollo Management Holdings, L.P. Portfolio

Follow Apollo Management Holdings, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollo Management Holdings, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Apollo Management Holdings, L.P. with notifications on news.